Skip to content

*Exploring cytokine detection in the stratum corneum of psoriasis patients by two noninvasive methods: sampling by TAPE and Transdermal Analysis Patches (TAP).*

*Exploring cytokine detection in the stratum corneum of psoriasis patients by two noninvasive methods: sampling by TAPE and Transdermal Analysis Patches (TAP).* - Cytokine detection in the stratum corneum in psoriasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49846
Enrollment
10
Registered
2020-05-12
Start date
2020-09-22
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriasis

Interventions

None listed

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: * Age * 18 years. * Willing to sign the informed consent. * Diagnosis of psoriasis according to a dermatologist. * At least 1 psoriasis plaque with a sufficient total surface of at least 2.5cm x 3.5cm in order to execute TAP and TAPE procedure within one lesion. Alternatively, 2 psoriasis plaques on the same body region with a similar SUM score with a total combined surface of at least 2.5cm x 3.5cm may be used.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: * No diagnosis of psoriasis. * Diagnosis of other inflammatory skin disease. * Not willing to participate or sign informed consent. * Not willing to stop topical treatment on the day of sampling. * Age

Design outcomes

Primary

MeasureTime frame
The main study endpoints are the Visual Analogue Scale (VAS) scores and the levels of cytokines measured by both TAP and TAPE procedure. The two VAS score (VAS-TAP and VAS-TAPE) will be used to study the possible discomfort and perception of patients by the removal of the TAP and the TAPE.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)